2022
DOI: 10.1002/ptr.7376
|View full text |Cite
|
Sign up to set email alerts
|

A meta‐analysis of prospective cohort studies of flavonoid subclasses and stroke risk

Abstract: Epidemiological studies indicate that higher intakes of flavonoids are associated with reduced stroke risk, however, which subtypes play significant roles to protect against stroke remain unclear. A systematic literature search in PubMed and Web of Science databases was performed up to Oct. 2021. Flavonoids or their subtypes (flavanol, flavanone, flavone, flavan-3-ol, isoflavone, or anthocyanin) were paired with stoke as the search term. Multivariate-adjusted relative risks (RRs) with 95% confidence intervals … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 56 publications
(129 reference statements)
0
1
0
Order By: Relevance
“…First, all the conclusions on the therapeutic effects of APG come from animal or cellular experiments, and its therapeutic mechanism in humans is not clear. Second, although flavonoids have been found to have preventive and therapeutic effects on CI, 109 the mechanism of long-term efficacy of APG in preventing CI has also not been experimentally proven. Finally, the most critical issue is how to achieve an effective dose of APG in the treatment of patients with CI.…”
Section: Limitations and Future Perspectives Of Apg In Cerebral Ischemiamentioning
confidence: 99%
“…First, all the conclusions on the therapeutic effects of APG come from animal or cellular experiments, and its therapeutic mechanism in humans is not clear. Second, although flavonoids have been found to have preventive and therapeutic effects on CI, 109 the mechanism of long-term efficacy of APG in preventing CI has also not been experimentally proven. Finally, the most critical issue is how to achieve an effective dose of APG in the treatment of patients with CI.…”
Section: Limitations and Future Perspectives Of Apg In Cerebral Ischemiamentioning
confidence: 99%